SCHEMBL7375682

SCHEMBL7375682

CCN(CC)CCNC(=O)c1cc2cc(N3CCC(Cc4ccccc4)CC3)[nH]c2cc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
ACHE P22303 2/20 0.47
BACE1 P56817 1/20 0.47
DRD2 P14416 3/20 0.46
DRD4 P21917 2/20 0.46
ADRA2A P08913 3/20 0.44
CYP2D6 P10635 3/20 0.44
DRD3 P35462 3/20 0.44
LMNA P02545 3/20 0.44
CYP1A2 P05177 2/20 0.44
HTR2B P41595 2/20 0.44
KCNH2 Q12809 2/20 0.44
HTR3E A5X5Y0 1/20 0.44
SLC22A1 O15245 1/20 0.44
HTR3B O95264 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MPO P05164 1/20 0.44
ADRA2C P18825 1/20 0.44
HTR2A P28223 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201673 0.82 MEN1 (0.59) MEN1KMT2AACHEBACE1CYP2C9
SCHEMBL7369230 0.77 MEN1 (0.47) MEN1KMT2AACHEBACE1DRD2
SCHEMBL7373279 0.74 SLC6A2 (0.51) MEN1KMT2A
SCHEMBL5372928 0.74 MAPK14 (0.48) MEN1KMT2AHTR4CYP2C9
SCHEMBL5365936 0.74 DRD2 (0.47) MEN1KMT2AACHEDRD2DRD4
SCHEMBL20883165 0.72 MAPK14 (0.61) MEN1KMT2ACYP2C9
SCHEMBL30301407 0.71 ACHE (0.75) MEN1KMT2AACHEBACE1LMNA
SCHEMBL27014556 0.71 ACHE (0.75) MEN1KMT2AACHEBACE1LMNA
SCHEMBL5374207 0.71 GPR84 (0.52) MEN1KMT2AHTR2BALDH1A1SMN1; SMN2
SCHEMBL1079888 0.70 MAPK14 (0.63) MEN1KMT2AACHELMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed